VIA
CME icon

Vident Investment Advisory’s CME Group CME Stock Holding History

Vident Investment Advisory’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-50,813
Closed -$9.42M – 214
2023
Q2 		$9.42M Sell
50,813
-4,152
-8% -$767K 0.32% 83
2023
Q1 		$10.5M Buy
54,965
+50,589
+1,156% +$9.15M 0.34% 62
2022
Q4 		$736K Buy
4,376
+998
+30% +$173K 0.03% 580
2022
Q3 		$426K Buy
3,378
+483
+17% +$95.5K 0.01% 815
2022
Q2 		$590K Sell
2,895
-9,181
-76% -$1.95M 0.02% 815
2022
Q1 		$2.87M Buy
12,076
+1,291
+12% +$303K 0.07% 293
2021
Q4 		$2.46M Sell
10,785
-711
-6% -$156K 0.06% 358
2021
Q3 		$2.22M Sell
11,496
-16,359
-59% -$3.31M 0.07% 352
2021
Q2 		$5.92M Buy
27,855
+6,476
+30% +$1.37M 0.18% 101
2021
Q1 		$4.37M Buy
21,379
+5,997
+39% +$1.18M 0.15% 123
2020
Q4 		$2.8M Buy
15,382
+1,914
+14% +$326K 0.11% 163
2020
Q3 		$2.25M Buy
13,468
+9,605
+249% +$1.62M 0.11% 171
2020
Q2 		$628K Sell
3,863
-975
-20% -$175K 0.03% 594
2020
Q1 		$836K Buy
4,838
+486
+11% +$96.7K 0.05% 449
2019
Q4 		$874K Sell
4,352
-665
-13% -$136K 0.05% 419
2019
Q3 		$1.06M Sell
5,017
-425
-8% -$88.8K 0.09% 169
2019
Q2 		$1.06M Sell
5,442
-98
-2% -$18.1K 0.09% 169
2019
Q1 		$912K Sell
5,540
-923
-14% -$163K 0.05% 431
2018
Q4 		$1.22M Buy
6,463
+754
+13% +$139K 0.07% 381
2018
Q3 		$972K Buy
5,709
+584
+11% +$98.3K 0.04% 479
2018
Q2 		$840K Buy
5,125
+978
+24% +$160K 0.03% 477
2018
Q1 		$683K Sell
4,147
-893
-18% -$142K 0.03% 492
2017
Q4 		$737K Sell
5,040
-1,717
-25% -$245K 0.03% 438
2017
Q3 		$917K Buy
+6,757
New +$854K 0.05% 377
2015
Q4 		– Sell
-54
Closed -$5K – 459
2015
Q3 		$5K Sell
54
-6,174
-99% -$587K ﹤0.01% 837
2015
Q2 		$580K Buy
6,228
+288
+5% +$26.9K 0.08% 410
2015
Q1 		$563K Buy
+5,940
New +$550K 0.11% 332

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Vident Investment Advisory's CME Position: Q3 2023 in Review

Vident Investment Advisory sold out of CME Group (CME) in Q3 2023, closing a stake of 50,813 shares — an estimated $9.42M sold.

Vident Investment Advisory first reported a position in CME in Q1 2015 and held it in 27 quarters. The position peaked at $10.5M in Q1 2023. 1,229 funds tracked by Wall St. Rank hold CME as of Q3 2023.

  • Vident Investment Advisory reported no remaining CME Group position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 50,813 CME Group shares in Q3 2023, an estimated $9.42M.
  • Vident Investment Advisory first reported a position in CME Group in Q1 2015 and held it in 27 quarters.
  • Vident Investment Advisory's CME Group position peaked at $10.5M in Q1 2023.
  • 1,229 funds tracked by Wall St. Rank held CME Group as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.